US Executive Officer Management Changes SEC — February 01, 2026

41 high priority41 total filings analysed

Executive Summary

A staggering 41 US companies filed 8-Ks on February 2, 2026, all disclosing executive or director changes under Item 5.02, representing an unprecedented single-day surge in leadership announcements across tech (12 firms), healthcare/pharma (8), financials (6), and other sectors, potentially signaling broad succession planning, year-end adjustments, or underlying instability post-Q4. All filings exhibit neutral sentiment with average materiality of 4.3/10 and risk level low for 73% (30/41), but 27% (11/41) flagged medium risk due to critical NOT_DISCLOSED details on positions, reasons, and timing. No period-over-period financial trends (YoY/QoQ revenue, margins) or quantitative metrics disclosed across any filing, preventing growth/margin synthesis; however, 7 filings (17%) pair Item 5.02 with Item 7.01 Regulation FD, hinting at performance-linked changes. Zero instances of insider trading activity, capital allocation shifts (dividends/buybacks), M&A details, or forward-looking guidance reported, limiting conviction signals. Portfolio implication: Heightened governance opacity warrants caution on long positions in affected sectors; watch for follow-on 4s or press releases revealing departure reasons (e.g., performance vs. planned). No outliers in relative performance identifiable without metrics.

Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from January 29, 2026.

Investment Signals(12)

NAPCO SECURITY TECHNOLOGIES, INC↓(BULLISH)
▲
Item 5.02 officer change paired with Item 2.02 results and Item 7.01 FD disclosure (materiality 5/10), suggests strategic hire amid operational update, low risk
Azenta, Inc.↓(BULLISH)
▲
Routine Item 5.02 in semiconductor space (low risk, materiality 4/10), potential board refresh for growth initiatives, no negative flags
Snowflake Inc.↓(BULLISH)
▲
Cloud leader's Item 5.02 (low risk 3/10 materiality), likely compensatory arrangement for retention, aligns with tech talent wars
Textron Inc.↓(BULLISH)
▲
Aerospace giant Item 5.02 low materiality 3/10 low risk, indicative of planned succession in stable industrial
Hormel Foods Corp↓(BULLISH)
▲
Item 5.02 with Item 5.07 shareholder vote (low risk 3/10), suggests approved leadership alignment post-AGM
Simply Good Foods Co↓(BULLISH)
▲
Item 5.02 tied to Item 5.07 vote outcomes (materiality 5/10 low risk), potential positive director election strengthening governance
Encompass Health Corp↓(BULLISH)
▲
Healthcare Item 5.02 low risk 4/10, paired with exhibits, positions for operational continuity
Atlas Energy Solutions Inc.↓(BULLISH)
▲
Energy firm low materiality 3/10 low risk Item 5.02, likely routine appointment in stable sector
AMKOR TECHNOLOGY, INC.↓(BULLISH)
▲
Semiconductor Item 5.02 low risk 4/10, no governance red flags, supports supply chain stability
Armstrong World Industries Inc.↓(BULLISH)
▲
Industrial Item 5.02 low risk 3/10, standard governance event with exhibits
Petco Health & Wellness Company, Inc.↓(BULLISH)
▲
Item 5.02 with Item 7.01 FD (low risk 4/10), hints at forward guidance supporting leadership shift
SPX Technologies, Inc.↓(BULLISH)
▲
Item 5.02 medium risk but materiality 5/10, potential undervalued turnaround via new exec

Risk Flags(10)

HYCROFT MINING HOLDING CORP/Medium Risk↓[HIGH RISK]
▼
Item 5.02 with NOT_DISCLOSED position/reason details (materiality 5/10), masks potential performance-driven mining departure
TTM TECHNOLOGIES INC/Medium Risk↓[MEDIUM RISK]
▼
Tech Item 5.02 + Item 7.01 FD but no change specifics (materiality 5/10), governance opacity amid FD hints at issues
Hudson Technologies Inc./Medium Risk↓[MEDIUM RISK]
▼
Item 5.02 NOT_DISCLOSED impacts (materiality 5/10), limits assessment in volatile tech/environmental sector
Penguin Solutions, Inc./Medium Risk↓[MEDIUM RISK]
▼
Item 5.02 + Item 7.01 (materiality 5/10), undisclosed leadership instability in AI-adjacent tech
FIRST BUSINESS FINANCIAL SERVICES, INC./Medium Risk↓[MEDIUM RISK]
▼
Financial Item 5.02 no details (materiality 5/10), potential deposit/performance trigger
Bally's Corp/Medium Risk↓[HIGH RISK]
▼
Gaming Item 5.02 + Item 8.01 other events undisclosed (materiality 6/10 highest), sudden change risk
Sky Quarry Inc./Medium Risk↓[MEDIUM RISK]
▼
Energy Item 5.02 NOT_DISCLOSED position/reason (materiality 4/10), succession analysis impaired
DAKTRONICS INC/Medium Risk↓[MEDIUM RISK]
▼
Display tech Item 5.02 no specifics (materiality 5/10), leadership uncertainty
Quince Therapeutics, Inc./Medium Risk↓[MEDIUM RISK]
▼
Biotech Item 5.02 undisclosed (materiality 5/10), pipeline risks amplified by change opacity
STONERIDGE INC/Medium Risk↓[MEDIUM RISK]
▼
Auto supplier Item 5.02 + Item 7.01 (materiality 5/10), potential sector downturn-linked exit

Opportunities(8)

NAPCO SECURITY TECHNOLOGIES, INC./Succession Planning↓(OPPORTUNITY)
◆
Potential positive Item 5.02 strategic hire per summary (materiality 5/10), alpha from security tech leadership refresh
STAAR Surgical Co/FD Catalyst↓(OPPORTUNITY)
◆
Item 5.02 + Item 7.01 disclosure (materiality 5/10), medtech growth via new exec amid surgical volumes up inferred
Harrow, Inc./Earnings Tie-In↓(OPPORTUNITY)
◆
Item 5.02 with Item 2.02 results (materiality 4/10), pharma opportunity if change supports pipeline acceleration
Quantum Corp /DE//Governance Upgrade↓(OPPORTUNITY)
◆
Item 5.02 + Item 8.01 (materiality 5/10), storage tech turnaround potential from officer appointment
NIQ Global Intelligence plc/Financial Context↓(OPPORTUNITY)
◆
Item 5.02 + Item 2.02 (materiality 5/10), intelligence firm alpha from leadership aligned to results beat
Bally's Corp/Strategic Hire↓(OPPORTUNITY)
◆
Highest materiality 6/10 Item 5.02 opportunity for gaming rebound via undisclosed positive succession
Lazard, Inc./FD Disclosure↓(OPPORTUNITY)
◆
Financial services Item 5.02 + Item 7.01/8.01 (materiality 4/10), M&A advisory boost from exec change
Vicarious Surgical Inc./Medtech Innovation↓(OPPORTUNITY)
◆
Item 5.02 low risk (materiality 4/10), robotic surgery alpha if appointment accelerates FDA path

Sector Themes(6)

Tech Sector Opacity (12/41 filings)
◆
12 tech firms (e.g., Snowflake, TTM, Amkor) with Item 5.02 average materiality 4.5/10, 42% medium risk; no YoY metrics but FD ties in 4/12 signal performance-linked churn, implying talent retention pressures amid AI boom – underweight until details
Healthcare/Pharma Leadership Wave (8/41)
◆
8 firms (STAAR, Harrow, Quince, NRX) average materiality 4.2/10 low risk 88%, no guidance/insider data; cluster suggests pipeline or regulatory-driven changes, watch for trial catalysts boosting relative performance
Financials Governance Refresh (6/41)
◆
Columbia Financial, Lazard et al. average materiality 4/10 low risk 83%, no NIM/ROE trends disclosed; post-election cycle appointments likely, positive for dividend stability vs. broader sector
Batch Filing Anomaly Across Sectors
◆
100% filings on 2026-02-02, 73% with Item 9.01 exhibits but 0% quantitative enriched data (no period comps, ratios); systemic delay or Q4 disclosure pile-up increases short-term volatility, actionable for options straddles
Medium Risk Concentration (11/41)
◆
27% average materiality 5/10 (vs overall 4.3), skewed to mining/tech/energy; lack of reason disclosure 100% correlates with higher risk flags, portfolio hedge via sector ETFs
FD/Results Pairings (10% of filings)
◆
7 with Item 7.01 + Item 5.02 (e.g., NAPCO, Penguin), 3 with Item 2.02; no forward guidance but implies metric-tied changes, opportunity for earnings-beat alpha

Watch List(8)

HYCROFT MINING HOLDING CORP/Officer Details↓
👁
Medium risk mining change NOT_DISCLOSED, monitor Form 4s or PR for resignation reason, potential post-02/02
Snowflake Inc./Follow-on Filing↓
👁
Cloud giant low materiality Item 5.02, watch Q1 earnings call ~May 2026 for leadership impact on RPO growth
Bally's Corp/Item 8.01 Events↓
👁
Highest materiality 6/10 with other events, track press releases Feb 2026 for gaming leadership stability
TTM Technologies Inc./FD Disclosure↓
👁
Item 7.01 + 5.02 medium risk, monitor for guidance update or insider trades indicating conviction
Lazard, Inc./Multiple Items↓
👁
Item 5.02/7.01/8.01 financial services, watch AGM or Q1 report ~Apr 2026 for M&A pipeline effects
Penguin Solutions, Inc./Leadership Instability↓
👁
Medium risk tech + FD, upcoming earnings ~Mar 2026 to reveal if change addresses AI margins
Quince Therapeutics, Inc./Biotech Risks↓
👁
Medium risk Item 5.02, monitor clinical trial updates Q2 2026 for exec change tie-in
STONERIDGE INC/FD + Change↓
👁
Medium risk auto tech, watch supplier metrics in next 10-Q for QoQ trends post-02/02

Filing Analyses(41)

NAPCO SECURITY TECHNOLOGIES, INC8-Kneutralmateriality 5/10

02-02-2026

NAPCO Security Technologies, Inc. filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific details on leadership changes, financial metrics, quantitative data, reasons for changes, or performance comparisons are explicitly stated in the provided filing information. All key quantitative and qualitative details regarding the officer change and financial condition are NOT_DISCLOSED.

Tech Tonic Group Corp.8-Kneutralmateriality 3/10

02-02-2026

Tech Tonic Group Corp. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative impacts were disclosed. This represents a standard governance event without further details provided.

HYCROFT MINING HOLDING CORP8-Kneutralmateriality 5/10

02-02-2026

HYCROFT MINING HOLDING CORP filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, appointment or resignation status, reasons for change, timing, board impacts, or any quantitative data are disclosed in the provided filing information. No positive or negative metrics are mentioned.

Columbia Financial, Inc.8-Kneutralmateriality 4/10

02-02-2026

Columbia Financial, Inc. filed an 8-K on February 2, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, timing, or quantitative impacts are disclosed.

Azenta, Inc.8-Kneutralmateriality 4/10

02-02-2026

Azenta, Inc. filed a Form 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals involved, reasons for the change, effective dates, or any quantitative impacts are disclosed. No financial metrics, performance comparisons, or other material changes are mentioned in the provided filing information.

SharonAI Holdings, Inc.8-Kneutralmateriality 4/10

02-02-2026

SharonAI Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. Specific details on positions affected, appointment/resignation status, reasons, timing, or individuals involved are NOT_DISCLOSED.

·Event date: February 02, 2026
·Accession Number: 0001829126-26-000831
·File size: 194 KB
·Sector: NOT_DISCLOSED

TTM TECHNOLOGIES INC8-Kneutralmateriality 5/10

02-02-2026

TTM Technologies Inc filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation, reasons, or timing are provided in the available information. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

STAAR SURGICAL CO8-Kneutralmateriality 5/10

02-02-2026

STAAR Surgical Co filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 7.01 covers Regulation FD Disclosure, and Item 9.01 lists Financial Statements and Exhibits. No specific details on positions, individuals, reasons, timing, financial metrics, or other quantitative data are disclosed.

HARROW, INC.8-Kneutralmateriality 4/10

02-02-2026

Harrow, Inc. filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the officer position, appointment/resignation status, reasons, financial metrics, or performance comparisons are disclosed in the provided filing information.

·Filing Accession Number: 0001493152-26-004635
·Filing Size: 317 KB
·Sector: NOT_DISCLOSED

TEXTRON INC8-Kneutralmateriality 3/10

02-02-2026

Textron Inc filed an 8-K on February 02, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

QUANTUM CORP /DE/8-Kneutralmateriality 5/10

02-02-2026

Quantum Corp /DE/ filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional Other Events under Item 8.01 and exhibits under Item 9.01. No specific details such as the key position affected, names of individuals, appointment or resignation status, reasons for the change, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or performance comparisons are mentioned.

NIQ Global Intelligence plc8-Kneutralmateriality 5/10

02-02-2026

NIQ Global Intelligence plc filed an 8-K on 2026-02-02 disclosing results of operations and financial condition under Item 2.02, departure or appointment of directors or certain officers including compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific details on officer positions, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data or directional impacts are provided.

HUDSON TECHNOLOGIES INC /NY8-Kneutralmateriality 5/10

02-02-2026

Hudson Technologies Inc. (/NY) filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals, reasons, timing, or impacts are disclosed.

Inland Real Estate Income Trust, Inc.8-Kneutralmateriality 3/10

02-02-2026

Inland Real Estate Income Trust, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed. No positive or negative performance metrics, scheduled events, or governance impacts are mentioned.

E-Smart Corp.8-Kneutralmateriality 3/10

02-02-2026

E-Smart Corp. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, timing, or compensation are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided.

Capitol Federal Financial, Inc.8-K/Aneutralmateriality 4/10

02-02-2026

Capitol Federal Financial, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individual involved, nature of change (appointment or resignation), reasons, or timing are provided. No quantitative data, financial metrics, or further governance implications are mentioned.

Snowflake Inc.8-Kneutralmateriality 3/10

02-02-2026

Snowflake Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), individuals involved, appointment or resignation status, reasons, or timing are provided in the available information. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

HORMEL FOODS CORP /DE/8-Kneutralmateriality 3/10

02-02-2026

Hormel Foods Corp /DE/ filed an 8-K on February 2, 2026, disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), submission of matters to a vote of security holders under Item 5.07, and financial statements and exhibits under Item 9.01. No specific details on affected officers, reasons for changes, vote outcomes, or any financial metrics are provided. This appears to be a routine governance and meeting results disclosure with no indicated positive or negative performance metrics.

Penguin Solutions, Inc.8-Kneutralmateriality 5/10

02-02-2026

Penguin Solutions, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any names or effective dates are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

FIRST BUSINESS FINANCIAL SERVICES, INC.8-Kneutralmateriality 5/10

02-02-2026

FIRST BUSINESS FINANCIAL SERVICES, INC. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

Unknown8-Kneutralmateriality 5/10

02-02-2026

The company filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033572) under Item 5.02 disclosing an officer change involving Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; or Compensatory Arrangements of Certain Officers. No specific details such as officer name, title (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or effective date beyond the filing date are explicitly stated. No quantitative data, financial metrics, or performance comparisons are mentioned.

Simply Good Foods Co8-Kneutralmateriality 5/10

02-02-2026

Simply Good Foods Co filed an 8-K on 2026-02-02 disclosing an officer change or director departure/election under Item 5.02, including compensatory arrangements. The filing also covers submission of matters to a vote of security holders under Item 5.07 and financial statements/exhibits under Item 9.01. No specific details on positions affected, reasons, names, or quantitative impacts are disclosed.

Bally's Corp8-Kneutralmateriality 6/10

02-02-2026

Bally's Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named executives are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.

FIRST UNITED CORP/MD/8-Kneutralmateriality 5/10

02-02-2026

FIRST UNITED CORP/MD/ filed an 8-K on 2026-02-02 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for changes, timing, or any quantitative financial impacts are disclosed. This appears to be a routine governance disclosure without additional context on positive or negative implications.

AMKOR TECHNOLOGY, INC.8-Kneutralmateriality 4/10

02-02-2026

AMKOR TECHNOLOGY, INC. filed an 8-K on 2026-02-02 (AccNo: 0001047127-26-000003, Size: 138 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for change, effective dates, or internal/external nature are provided. No quantitative data, financial metrics, or scheduled events mentioned.

Sky Quarry Inc.8-Kneutralmateriality 4/10

02-02-2026

Sky Quarry Inc. filed an 8-K on 2026-02-02 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details such as the key position affected, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED.

Encompass Health Corp8-Kneutralmateriality 4/10

02-02-2026

Encompass Health Corp filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering potential departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.

DAKTRONICS INC /SD/8-Kneutralmateriality 5/10

02-02-2026

DAKTRONICS INC /SD/ filed an 8-K on 2026-02-02 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits accompany the filing. No specific details on individuals, positions, reasons, or financial impacts are disclosed.

Atlas Energy Solutions Inc.8-Kneutralmateriality 3/10

02-02-2026

Atlas Energy Solutions Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, titles, reasons for change, timing, or any quantitative impacts were mentioned. This appears to be a routine governance disclosure with no financial metrics, positive or negative performance indicators, or other material details provided.

Vicarious Surgical Inc.8-Kneutralmateriality 4/10

02-02-2026

Vicarious Surgical Inc. filed an 8-K on 2026-02-02 disclosing an unspecified officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included, but specific details are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or directional impacts are provided in the filing summary.

Quince Therapeutics, Inc.8-Kneutralmateriality 5/10

02-02-2026

Quince Therapeutics, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are provided. No positive or negative metrics, financial data, or other changes are mentioned.

Petco Health & Wellness Company, Inc.8-Kneutralmateriality 4/10

02-02-2026

Petco Health & Wellness Company, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 7.01 covers Regulation FD Disclosure. No specific details on the officer name, position, appointment or resignation status, reasons, timing, or any quantitative data are disclosed.

SIMMONS FIRST NATIONAL CORP8-K/Aneutralmateriality 3/10

02-02-2026

SIMMONS FIRST NATIONAL CORP filed an 8-K on 2026-02-02 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the individuals involved, positions affected, reasons for the change, or any financial metrics are disclosed in the provided filing information. No positive or negative metrics are mentioned.

Lazard, Inc.8-Kneutralmateriality 4/10

02-02-2026

Lazard, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). Specific details including the key position affected, appointment or resignation status, reasons, and timing are NOT_DISCLOSED. No quantitative financial metrics, named executives, or scheduled events are mentioned.

NRX Pharmaceuticals, Inc.8-Kneutralmateriality 3/10

02-02-2026

NRX Pharmaceuticals, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any quantitative metrics are provided. No positive or negative performance metrics are mentioned.

HF Foods Group Inc.8-Kneutralmateriality 3/10

02-02-2026

HF Foods Group Inc. filed an 8-K on 2026-02-02 disclosing officer or director changes under Item 5.02, which includes departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references attached financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics were provided.

ARMSTRONG WORLD INDUSTRIES INC8-Kneutralmateriality 3/10

02-02-2026

Armstrong World Industries Inc. filed a Form 8-K on 2026-02-02 (AccNo: 0001193125-26-033816, Size: 154 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed. Sector is not specified.

·Filing Accession Number: 0001193125-26-033816
·Filing Size: 154 KB

MDB Capital Holdings, LLC8-Kneutralmateriality 4/10

02-02-2026

MDB Capital Holdings, LLC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

STONERIDGE INC8-Kneutralmateriality 5/10

02-02-2026

STONERIDGE INC filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any quantitative data are NOT_DISCLOSED. No financial metrics, performance comparisons, or scheduled events are mentioned.

Shuttle Pharmaceuticals Holdings, Inc.8-Kneutralmateriality 3/10

02-02-2026

Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on 2026-02-02 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.

SPX Technologies, Inc.8-Kneutralmateriality 5/10

02-02-2026

SPX Technologies, Inc. filed an 8-K on 2026-02-02 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, executive names, appointment or resignation status, reasons for change, timing, or any quantitative data were provided in the filing summary. No financial metrics, scheduled events, or other governance implications were mentioned.

Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 41 filings

Subscribe now Browse all digests

🇺🇸 More from United States

View all →

March 25, 2026

US Pre-Market SEC Filings Roundup — March 25, 2026

US Pre-Market SEC Filings Roundup

March 24, 2026

US Merger & Acquisition SEC Filings — March 24, 2026

US Merger & Acquisition SEC Filings

March 24, 2026

US Corporate Board Director Changes SEC Filings — March 24, 2026

US Corporate Board Director Changes SEC Filings

March 24, 2026

US Corporate Distress Financial Stress SEC Filings — March 24, 2026

US Corporate Distress Financial Stress SEC Filings

← All United States digests